HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-MAR-11 3R71 TITLE CDK2 IN COMPLEX WITH INHIBITOR KVR-1-162 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CDK2, CELL DIVISION PROTEIN KINASE 2, P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: TUNER(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX6P-1 KEYWDS PROTEIN KINASE, INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.BETZI,R.ALAM,H.HAN,A.BECKER,E.SCHONBRUNN REVDAT 2 13-SEP-23 3R71 1 REMARK SEQADV REVDAT 1 08-AUG-12 3R71 0 JRNL AUTH E.SCHONBRUNN,A.BECKER,S.BETZI,R.ALAM,H.HAN,F.RAWLE,V.KATTA, JRNL AUTH 2 J.JAKKARAJ,R.CHAKRASALI,S.NEELAM,D.HOOK,J.TASH,G.GEORG JRNL TITL STRUCTURE-GUIDED OPTIMIZATION OF NOVEL CDK2 INHIBITORS JRNL TITL 2 DISCOVERED BY HIGH-THROUGHPUT SCREENING JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1499443.920 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 28694 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1105 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.86 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4545 REMARK 3 BIN R VALUE (WORKING SET) : 0.2230 REMARK 3 BIN FREE R VALUE : 0.2740 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 182 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2366 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 245 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.46000 REMARK 3 B22 (A**2) : -1.16000 REMARK 3 B33 (A**2) : -0.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.10 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.14 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.940 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.170 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.880 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.790 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.630 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 55.08 REMARK 3 REMARK 3 NCS MODEL : NONE REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : INH.PAR REMARK 3 PARAMETER FILE 4 : EDO.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : INH.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : EDO.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 3R71 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAR-11. REMARK 100 THE DEPOSITION ID IS D_1000064569. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JAN-09 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28698 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 4.320 REMARK 200 R MERGE (I) : 0.10500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.8900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.22 REMARK 200 R MERGE FOR SHELL (I) : 0.20200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 6.520 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS 1.2 REMARK 200 STARTING MODEL: PDB ENTRY 1PW2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.69 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 5 MG/ML CDK2 PROTEIN, 3 MM INHIBITOR, REMARK 280 15% V/V PEG3350, 50 MM HEPES/NAOH, 50 MM NA/K PHOSPHATE, PH 7.5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.91000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.09000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.90500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.09000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.91000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.90500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -7 REMARK 465 PRO A -6 REMARK 465 LEU A -5 REMARK 465 GLY A -4 REMARK 465 SER A -3 REMARK 465 PRO A -2 REMARK 465 GLU A -1 REMARK 465 PHE A 0 REMARK 465 LEU A 37 REMARK 465 ASP A 38 REMARK 465 THR A 39 REMARK 465 GLU A 40 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 2 -55.99 -163.89 REMARK 500 VAL A 44 101.11 60.43 REMARK 500 ARG A 126 -19.56 82.29 REMARK 500 HIS A 161 5.23 80.47 REMARK 500 PRO A 254 41.92 -105.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 799 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE X86 A 800 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3QL8 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR JWS-6-260 REMARK 900 RELATED ID: 3QQF RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L1 REMARK 900 RELATED ID: 3QQG RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L2-5 REMARK 900 RELATED ID: 3QQH RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L2-2 REMARK 900 RELATED ID: 3QQJ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L2 REMARK 900 RELATED ID: 3QQK RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L4 REMARK 900 RELATED ID: 3QQL RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L3 REMARK 900 RELATED ID: 3QRT RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR NSK-MC2-55 REMARK 900 RELATED ID: 3QRU RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-12 REMARK 900 RELATED ID: 3QTQ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-137 REMARK 900 RELATED ID: 3QTR RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-148 REMARK 900 RELATED ID: 3QTS RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-12 REMARK 900 RELATED ID: 3QTU RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-132 REMARK 900 RELATED ID: 3QTW RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-13 REMARK 900 RELATED ID: 3QTX RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-35 REMARK 900 RELATED ID: 3QTZ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-36 REMARK 900 RELATED ID: 3QU0 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-38 REMARK 900 RELATED ID: 3QWJ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-142 REMARK 900 RELATED ID: 3QWK RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-150 REMARK 900 RELATED ID: 3QX2 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-190 REMARK 900 RELATED ID: 3QX4 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-78 REMARK 900 RELATED ID: 3QXO RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-84 REMARK 900 RELATED ID: 3QXP RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-3-89 REMARK 900 RELATED ID: 3QZF RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR JWS-6-52 REMARK 900 RELATED ID: 3QZG RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR JWS-6-76 REMARK 900 RELATED ID: 3QZH RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-124 REMARK 900 RELATED ID: 3QZI RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-126 REMARK 900 RELATED ID: 3R1Q RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-102 REMARK 900 RELATED ID: 3R1S RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-127 REMARK 900 RELATED ID: 3R1Y RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-134 REMARK 900 RELATED ID: 3R28 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-140 REMARK 900 RELATED ID: 3R6X RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-158 REMARK 900 RELATED ID: 3R73 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-164 REMARK 900 RELATED ID: 3R7E RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-67 REMARK 900 RELATED ID: 3R7I RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-74 REMARK 900 RELATED ID: 3R7U RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-75 REMARK 900 RELATED ID: 3R7V RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-9 REMARK 900 RELATED ID: 3R7Y RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-2-88 REMARK 900 RELATED ID: 3R83 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-2-92 REMARK 900 RELATED ID: 3R8L RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L3-4 REMARK 900 RELATED ID: 3R8M RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L3-3 REMARK 900 RELATED ID: 3R8P RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-6 REMARK 900 RELATED ID: 3R8U RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-132 REMARK 900 RELATED ID: 3R8V RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-135 REMARK 900 RELATED ID: 3R8Z RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-136 REMARK 900 RELATED ID: 3R9D RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-135 REMARK 900 RELATED ID: 3R9H RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-142 REMARK 900 RELATED ID: 3R9N RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-21 REMARK 900 RELATED ID: 3R9O RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-143 REMARK 900 RELATED ID: 3RAH RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-22 REMARK 900 RELATED ID: 3RAI RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-160 REMARK 900 RELATED ID: 3RAK RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-32 REMARK 900 RELATED ID: 3RAL RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-34 REMARK 900 RELATED ID: 3RJC RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L4-12 REMARK 900 RELATED ID: 3RK5 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-72 REMARK 900 RELATED ID: 3RK7 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-71 REMARK 900 RELATED ID: 3RK9 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-74 REMARK 900 RELATED ID: 3RKB RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-73 REMARK 900 RELATED ID: 3RM6 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-2-80 REMARK 900 RELATED ID: 3RM7 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-91 REMARK 900 RELATED ID: 3RMF RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-33 REMARK 900 RELATED ID: 3RNI RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-3-86 REMARK 900 RELATED ID: 3ROY RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-154 REMARK 900 RELATED ID: 3RPO RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR KVR-1-156 REMARK 900 RELATED ID: 3RPR RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-49 REMARK 900 RELATED ID: 3RPV RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-88 REMARK 900 RELATED ID: 3RPY RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-40 REMARK 900 RELATED ID: 3RZB RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-23 REMARK 900 RELATED ID: 3S00 RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR L4-14 REMARK 900 RELATED ID: 3S0O RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-1-138 REMARK 900 RELATED ID: 3S1H RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-2-39 REMARK 900 RELATED ID: 3SQQ RELATED DB: PDB REMARK 900 CDK2 IN COMPLEX WITH INHIBITOR RC-3-96 DBREF 3R71 A 1 298 UNP P24941 CDK2_HUMAN 1 298 SEQADV 3R71 GLY A -7 UNP P24941 EXPRESSION TAG SEQADV 3R71 PRO A -6 UNP P24941 EXPRESSION TAG SEQADV 3R71 LEU A -5 UNP P24941 EXPRESSION TAG SEQADV 3R71 GLY A -4 UNP P24941 EXPRESSION TAG SEQADV 3R71 SER A -3 UNP P24941 EXPRESSION TAG SEQADV 3R71 PRO A -2 UNP P24941 EXPRESSION TAG SEQADV 3R71 GLU A -1 UNP P24941 EXPRESSION TAG SEQADV 3R71 PHE A 0 UNP P24941 EXPRESSION TAG SEQRES 1 A 306 GLY PRO LEU GLY SER PRO GLU PHE MET GLU ASN PHE GLN SEQRES 2 A 306 LYS VAL GLU LYS ILE GLY GLU GLY THR TYR GLY VAL VAL SEQRES 3 A 306 TYR LYS ALA ARG ASN LYS LEU THR GLY GLU VAL VAL ALA SEQRES 4 A 306 LEU LYS LYS ILE ARG LEU ASP THR GLU THR GLU GLY VAL SEQRES 5 A 306 PRO SER THR ALA ILE ARG GLU ILE SER LEU LEU LYS GLU SEQRES 6 A 306 LEU ASN HIS PRO ASN ILE VAL LYS LEU LEU ASP VAL ILE SEQRES 7 A 306 HIS THR GLU ASN LYS LEU TYR LEU VAL PHE GLU PHE LEU SEQRES 8 A 306 HIS GLN ASP LEU LYS LYS PHE MET ASP ALA SER ALA LEU SEQRES 9 A 306 THR GLY ILE PRO LEU PRO LEU ILE LYS SER TYR LEU PHE SEQRES 10 A 306 GLN LEU LEU GLN GLY LEU ALA PHE CYS HIS SER HIS ARG SEQRES 11 A 306 VAL LEU HIS ARG ASP LEU LYS PRO GLN ASN LEU LEU ILE SEQRES 12 A 306 ASN THR GLU GLY ALA ILE LYS LEU ALA ASP PHE GLY LEU SEQRES 13 A 306 ALA ARG ALA PHE GLY VAL PRO VAL ARG THR TYR THR HIS SEQRES 14 A 306 GLU VAL VAL THR LEU TRP TYR ARG ALA PRO GLU ILE LEU SEQRES 15 A 306 LEU GLY CYS LYS TYR TYR SER THR ALA VAL ASP ILE TRP SEQRES 16 A 306 SER LEU GLY CYS ILE PHE ALA GLU MET VAL THR ARG ARG SEQRES 17 A 306 ALA LEU PHE PRO GLY ASP SER GLU ILE ASP GLN LEU PHE SEQRES 18 A 306 ARG ILE PHE ARG THR LEU GLY THR PRO ASP GLU VAL VAL SEQRES 19 A 306 TRP PRO GLY VAL THR SER MET PRO ASP TYR LYS PRO SER SEQRES 20 A 306 PHE PRO LYS TRP ALA ARG GLN ASP PHE SER LYS VAL VAL SEQRES 21 A 306 PRO PRO LEU ASP GLU ASP GLY ARG SER LEU LEU SER GLN SEQRES 22 A 306 MET LEU HIS TYR ASP PRO ASN LYS ARG ILE SER ALA LYS SEQRES 23 A 306 ALA ALA LEU ALA HIS PRO PHE PHE GLN ASP VAL THR LYS SEQRES 24 A 306 PRO VAL PRO HIS LEU ARG LEU HET EDO A 799 4 HET X86 A 800 26 HETNAM EDO 1,2-ETHANEDIOL HETNAM X86 4-[(3-METHOXYPROPYL)AMINO]-5-NITRO-2-[(PYRIDIN-3- HETNAM 2 X86 YLMETHYL)AMINO]BENZAMIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 2 EDO C2 H6 O2 FORMUL 3 X86 C17 H21 N5 O4 FORMUL 4 HOH *245(H2 O) HELIX 1 1 PRO A 45 LEU A 55 1 11 HELIX 2 2 LYS A 56 LEU A 58 5 3 HELIX 3 3 LEU A 87 SER A 94 1 8 HELIX 4 4 PRO A 100 HIS A 121 1 22 HELIX 5 5 LYS A 129 GLN A 131 5 3 HELIX 6 6 GLY A 147 GLY A 153 1 7 HELIX 7 7 ALA A 170 LEU A 175 1 6 HELIX 8 8 THR A 182 ARG A 199 1 18 HELIX 9 9 SER A 207 GLY A 220 1 14 HELIX 10 10 GLY A 229 MET A 233 5 5 HELIX 11 11 ASP A 247 VAL A 252 1 6 HELIX 12 12 ASP A 256 LEU A 267 1 12 HELIX 13 13 SER A 276 ALA A 282 1 7 HELIX 14 14 HIS A 283 VAL A 289 5 7 SHEET 1 A 5 PHE A 4 GLU A 12 0 SHEET 2 A 5 VAL A 17 ASN A 23 -1 O LYS A 20 N GLU A 8 SHEET 3 A 5 VAL A 29 ILE A 35 -1 O LEU A 32 N TYR A 19 SHEET 4 A 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 A 5 LEU A 66 THR A 72 -1 N ASP A 68 O VAL A 79 SHEET 1 B 3 GLN A 85 ASP A 86 0 SHEET 2 B 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 B 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 CISPEP 1 PRO A 253 PRO A 254 0 0.26 SITE 1 AC1 7 THR A 137 GLU A 138 GLU A 257 ARG A 260 SITE 2 AC1 7 SER A 261 HOH A 353 HOH A 649 SITE 1 AC2 16 ILE A 10 GLY A 11 GLU A 12 VAL A 18 SITE 2 AC2 16 ALA A 31 LYS A 33 GLU A 81 PHE A 82 SITE 3 AC2 16 LEU A 83 HIS A 84 GLN A 85 ASP A 86 SITE 4 AC2 16 LEU A 134 HOH A 355 HOH A 454 HOH A 559 CRYST1 53.820 71.810 72.180 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018580 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013926 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013854 0.00000